These Three Speculative Companies Are Loved By Insiders and Institutions

Small-cap pharmaceutical companies are as risky as they come. To combat this, investors look at how insiders and institutions are playing these firms with their significant expertise and inside scoop. Anacor Pharmaceuticals (NASDAQ: ANAC ) develops small molecule therapeutics, the majority of which are used topically. The company also brings